Apex Bioscience, Inc.
13Patents
0Active
13Granted
29Portfolio score
Filing activity: May 24, 1993 → Aug 21, 2001
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5480866A | Hemoproteins for inhibition of nitric oxide-mediated hypotension and septic shock | Emerging Cross-Sectional Technologies | 26 | Expired |
| US5554638A | Methods for improving therapeutic effectiveness of agents for the treatment of solid tumors and other disorders | Human Necessities | 23 | Expired |
| US5612310A | Methods for improving therapeutic effectiveness of agents for the treatment of solid tumors and other disorders | Human Necessities | 16 | Expired |
| US5827693A | Expression of recombinant hemoglobin and hemoglobin variants in yeast | Emerging Cross-Sectional Technologies | 11 | Expired |
| US6747132B2 | Methods for the synthesis of a modified hemoglobin solution | Emerging Cross-Sectional Technologies | 8 | Expired |
| US7038016B2 | Methods for purification of an activated PEG solution and for the synthesis of a modified hemoglobin solution | Emerging Cross-Sectional Technologies | 8 | Expired |
| US6172039A | Expression of recombinant hemoglobin and hemoglobin variants in yeast | Emerging Cross-Sectional Technologies | 8 | Expired |
| US5674836A | Treatment of septic shock with iron-containing hemoprotein | Emerging Cross-Sectional Technologies | 4 | Expired |
| US6103690A | Prevention or inhibition of pathogenic syndromes caused by nitric oxide overproduction using iron-containing hemoprotein | Emerging Cross-Sectional Technologies | 3 | Expired |
| US6020308A | Methods for improving therapeutic effectiveness of treatment of vascularization disorders | Human Necessities | 3 | Expired |
| US5788958A | Methods for improving therapeutic effectiveness of agents for the treatment of solid tumors and other disorders | Human Necessities | 3 | Expired |
| US5900403A | Use of iron hemoprotein for treating pathogenic syndrome caused by nitric oxide overproduction | Emerging Cross-Sectional Technologies | 2 | Expired |
| US6350729B1 | Inhibition of nitric oxide-mediated hypotension and septic shock with iron-containing hemoprotein | Emerging Cross-Sectional Technologies | 0 | Expired |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.